Clofarabine/Ara-C Treatment Combined With Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Primary Treatment Failure
NCT01188174
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class
Conditions
AML
Interventions
DRUG:
Clofarabine
Sponsor
Nantes University Hospital